Drugs / Biotene
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00595933 | Mar 2005 → Jun 2010 | — | University of Oklahoma | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00138827 | Nov 1999 → Mar 2003 | head and neck neoplasm | St George Hospital, Australia | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02539342 Comparator | Oct 2016 → Mar 2017 | chemotherapy-induced oral mucositis | Medical College of Wisconsin | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biotene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02539342 ↗ |
| Known as | mouth spray | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00595933 ↗ |
| Route | Other | “Spray mouth with mouth spray 4 times a day with additional allowances for as needed” NCT00595933 ↗ |